2-deoxy-D-glucose (SENTAN/Kawasaki Medical School)

N/A

Report date: 2025/01/26 18:30:55
NME

Base Information

Drug Name2-deoxy-D-glucose (SENTAN/Kawasaki Medical School)
Drug Alias Name2-deoxy-D-glucose nanoparticles (SENTAN/Kawasaki Medical School)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycolysis pathway modulators
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSENTAN Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesSENTAN Pharma IncKawasaki Medical School
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A